Prof Robert Thomas, who leads the Integrative Oncology Department at the Royal London Hospital for Integrated Medicine, has been gathering data on the conditions they’ve treated and will share insights on how patients have experienced far greater benefits than he initially expected.

Dr. Longo's studies show that the fasting-mimicking diet is beginning to make cancer therapies potentially more effective and less toxic to patients, thus providing an evidence-based complementary approach to mainstream treatments.

Dr James Kinross, reader in colorectal surgery and a consultant surgeon at Imperial College London, where his research team are trying to engineer the microbiome to improve cancer therapy and reduce the adverse side effects of chemotherapy.

Physical activity in oncology has transcended its role in prevention, emerging as a vital component of cancer therapy with the potential to transform patient outcomes. Darryl Edwards will highlight the barriers for integrating physical activity into clincial practice and highlight practical, evidence-based approaces for therapeutic exercise across the continuum of cancer care.

The growing demand for integrative cancer care reveals gaps in patient treatment, with many turning to unverified or harmful options due to insufficient research methods. Dr HariHaran Kuhan will discuss the need to establish reliable evidence based clinical services that emphasise metabolic oncology, the need to gather comprehensive longitudinal data collection and how collaborating with public health authorities will facilitate a more representative patient population, enhancing the robustness of research.

Dr Sam Watts will explore the clinical and evidential synergy between the Western and Ayurvedic understanding of exceptional cancer survival, the mechanisms that are predictive of this state and how Ayurveda can provide a unified framework for the adoption of these mechanisms. 

Mistletoe therapy is a complementary treatment used in integrative oncology to support cancer patients by stimulating the immune system.  Dr Nasha Winters will highlight how mistletoe therapy is utilised in a holistic approach to cancer treatment, emphasizing its potential to reduce side effects of conventional treatments, such as chemotherapy, while promoting healing and vitality. 

The Panel will discuss the potential benefits of using Psychedelic treatment for cancer patients. Research in this area is still ongoing, but early studies have shown promising results, particularly when used in conjunction with psychological support from trained professionals.   

 

 

Dr Wafaa will highlight the importance of understanding cancer dynamics and will discuss affordable and non-negotiable tests that she utilises.  She will also highlight key lifestyle changes, which are simple, affordable, and done at home, are vital for controlling the cancer microenvironment and enhancing treatment success. 

 

Dr Jeffrey Rediger is an instructor in psychiatry at Harvard Medical School and medical director for the McLean SouthEast Adult Psychiatric Programmes and is the author of the New York Times best-seller 'Cured - The Remarkable Science and Stories of Spontaneous Healing and Recovery'.  By exploring the extraordinary stories of those who have recovered from terminal illnesses, Dr Jeff Rediger reveals the immense power of our immune systems.